{"id":"W3163731137","doi":"10.1016/j.euo.2021.04.008","title":"Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)","year":2021,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Clinical endpoint; Prostate cancer; Hazard ratio; Androgen deprivation therapy; Population; Prostatectomy; Internal medicine; Urology; Testosterone (patch); Prostate-specific antigen; Biochemical recurrence; Randomized controlled trial; Confidence interval; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001988113,0.0002596819,0.002253952,0.0002565489,0.00003872082,0.000009110639,0.00008575858,0.0001345773,0.0003436031],"category_scores_gemma":[0.0007834952,0.0001457574,0.0002362972,0.0003431186,0.0005057172,0.0000454684,0.00005543961,0.0004074438,0.0000103773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001230087,"about_ca_system_score_gemma":0.00153983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005527393,"about_ca_topic_score_gemma":0.0001048152,"domain_scores_codex":[0.9948639,0.003074733,0.0009034286,0.0005058524,0.0002341647,0.0004179455],"domain_scores_gemma":[0.9975389,0.001181194,0.0004956934,0.0003115138,0.0003407002,0.0001319651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9445999,0.003491794,0.01998028,0.00003251148,0.001001399,0.001686306,0.0004721218,0.000003661489,0.002160246,0.000005629076,0.0001855548,0.02638066],"study_design_scores_gemma":[0.9832635,0.007390158,0.001323272,0.00005514665,0.0004686966,0.00007895456,0.00002639902,0.00007135153,0.004539859,0.00003212543,0.002602931,0.0001476204],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858949,0.006431571,0.00003546035,0.002444785,0.0003512898,0.004177641,0.00002936734,0.00003239826,0.0006025528],"genre_scores_gemma":[0.9814597,0.01529668,0.0002809309,0.0005595883,0.0002177638,0.001325069,0.0001195005,0.0000470105,0.0006937147],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03866364,"threshold_uncertainty_score":0.5943813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0251811069725022,"score_gpt":0.3379748630675485,"score_spread":0.3127937560950463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}